Mirin is a MRE11 nuclease inhibitor and it induced oral cancer cell death at 25 and 50 μM, but not at 12.5 μM, when compared with untreated controls (Fig. S1H) [14]. The gene discussed is MRE11; the disease is lip and oral cavity carcinoma.